At Exelixis, the mission extends beyond developing medicines for patients. They are dedicated to supporting organizations focusing on improving cancer education, outreach, and advocacy. This commitment includes giving initiatives designed to enhance their impact and create partnerships that benefit patients, healthcare providers, and researchers. Their approach encompasses educational requests, sponsorships, charitable contributions, and volunteerism, all driven by a spirit of generosity and collaboration to serve communities.
Exelixis's grant program supports various initiatives geared towards oncology and cancer awareness, patient education, advocacy, access to treatments, and healthcare-related support. They fund:
The focus of Exelixis’s grant program lies within the therapeutic area of oncology, particularly diseases like renal cell carcinoma, hepatocellular carcinoma, thyroid cancer, and prostate cancer, although proposals for other cancer types or therapeutic areas may be considered if they align with Exelixis's annual plans.